Back to News
Market Impact: 0.35

Truist Securities Initiates Coverage of Inventiva S.A. - Depositary Receipt (IVA) with Buy Recommendation

IVA
Analyst InsightsAnalyst EstimatesCompany FundamentalsHealthcare & Biotech

On March 19, 2026, Truist Securities initiated coverage of Inventiva S.A. (Nasdaq: IVA) with a Buy recommendation and an analyst price forecast implying 160.87% upside. The initiation and large target signal a materially bullish analyst view that could drive re-rating and elevated trading interest in the stock.

Analysis

On March 19, 2026, Truist Securities initiated coverage of Inventiva S.A. (Nasdaq: IVA) with a Buy recommendation and an analyst price forecast implying 160.87% upside. The initiation and large target signal a materially bullish analyst view that could drive re-rating and elevated trading interest in the stock.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Demo

Market Sentiment

Overall Sentiment

strongly positive

Sentiment Score

0.60

Ticker Sentiment

IVA0.60